Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Researcher Spotlight

Dec 1, 2024/Article

Jim Gordon, PT, EdD, FAPTA, takes stock of his research journey and the challenges that remain.

Researcher Spotlight

May 1, 2024/Column

Julie Fritz, PT, PhD, FAPTA, shares experiences translating research into practice and being a peer reviewer.

Laycock Pelvic Floor Manual Muscle Test Scale

Aug 23, 2017/Test & Measure

A 6 point Oxford scale (0=no contraction, 1=flicker, 2=weak, 3=moderate, 4=good (with lift), and 5=strong) used during internal examination to measure pelvic floor muscle strength in women. (4)

APTA-Backed Bill Presses for Medicare Advantage Prior Authorization Reforms

May 17, 2021/News

The legislation would require MA plans to share data, provide transparency, create more efficient systems, and do a better job of listening.

Physical Therapy: At the Intersection of Public Health and Health Care

Apr 1, 2024/Feature

A perspective on who makes up the public health workforce, and physical therapists' contributions to promoting a community's health and wellness.

Financial Health and Money Matters

May 20, 2020/Podcast

Financial experts Kevin Soehner from Enrich and Alexander Macielak, Laurel Road discuss tools available in the APTA Financial Solutions Center.

Embracing the Wall

Jun 1, 2017/Column

Barriers are inevitable. They needn't be roadblocks.

APTA Advocacy Visit Report

APTA advocates can report their meetings and interactions with members of Congress and their staff using the form below. Meeting feedback and information is critical for the APTA Government Affairs team to further connect and follow up with legislators and their staff in their work on Capitol Hill. Questions?

News and Publications

We provide the content that you trust, empowering you with the information and resources you need to advance your career.

Advocacy for the Physical Therapy Profession

We are the leading voice of the profession with members of Congress, regulatory agencies, and commercial payers.